PPA
RARX

Parametric Portfolio Associates’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Parametric Portfolio Associates’s Portfolio RARX Stock Details RARX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-26,247
Closed -$1.26M – 4077
2020
Q1 		$1.26M Buy
26,247
+9,363
+55% +$436K ﹤0.01% 2667
2019
Q4 		$792K Sell
16,884
-36,889
-69% -$1.63M ﹤0.01% 3170
2019
Q3 		$1.27M Sell
53,773
-2,846
-5% -$84.3K ﹤0.01% 2897
2019
Q2 		$1.7M Buy
56,619
+3,352
+6% +$76.8K ﹤0.01% 2775
2019
Q1 		$1.19M Buy
53,267
+39,898
+298% +$858K ﹤0.01% 2943
2018
Q4 		$243K Buy
13,369
+2,145
+19% +$33.7K ﹤0.01% 3592
2018
Q3 		$203K Buy
+11,224
New +$133K ﹤0.01% 3757
2018
Q2 		– Sell
-11,038
Closed -$59K – 3997
2018
Q1 		$59K Buy
+11,038
New +$78.9K ﹤0.01% 3896

Other funds holding RARX

Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Parametric Portfolio Associates's RARX Position: Q2 2020 in Review

Parametric Portfolio Associates sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 26,247 shares — an estimated $1.26M sold.

Parametric Portfolio Associates first reported a position in RARX in Q1 2018 and held it in 8 quarters. The position peaked at $1.7M in Q2 2019. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

  • Parametric Portfolio Associates reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Parametric Portfolio Associates sold 26,247 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $1.26M.
  • Parametric Portfolio Associates first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2018 and held it in 8 quarters.
  • Parametric Portfolio Associates's Ra Pharmaceuticals, Inc. Common Stock position peaked at $1.7M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Parametric Portfolio Associates's 13F filing for Q2 2020, filed 13 Aug 2020.